MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 201 to 220 of 30,876 approvalsPage 11 of 1544

Dilatair

Issued: Mar 31, 2025

Brizol

Issued: Mar 31, 2025

Norpriexia Forte

Issued: Mar 31, 2025

Vitacore

Issued: Mar 31, 2025

Noxprivex

Issued: Mar 31, 2025

Ameciron

Issued: Mar 31, 2023

None

Issued: Mar 31, 2023

Ramezole

Issued: Mar 31, 2023

Blefime

Issued: Mar 31, 2023

Prosride

Issued: Mar 31, 2023

Gosterid

Issued: Mar 31, 2023

Metforze

Issued: Mar 31, 2023

Goflex

Issued: Mar 31, 2023

Akurit-Z Kid

Issued: Mar 31, 2023

None

Issued: Mar 31, 2023
Euro-Med Laboratories Phil., Inc.

Zoloft

Issued: Mar 31, 2023

Doxan

Issued: Mar 31, 2023

Centravim

Issued: Mar 31, 2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.